证券代码：002226 证券简称：江南化工 公告编号:2025-070 安徽江南化工股份有限公司 2、本次续聘会计师事务所符合财政部、国务院国资委、证监会印发的《国有企 业、上市公司选聘会计师事务所管理办法》（财会〔2023〕4 号）的规定。 公司于2025年12月5日召开第七届董事会第十次会议，审议通过了《关于续聘会 计师事务所的议案》，拟续聘中审众环会计师事务所（特殊普通合伙）为本公司2025 年度财务报告及内部控制审计机构。现将相关事项公告如下： 一、拟聘任会计师事务所事项的情况说明 中审众环会计师事务所（特殊普通合伙）具有从事证券期货业务相关审计资格， 具备为上市公司提供审计服务的经验与能力，在为公司提供审计服务的工作中，能 够遵循独立、 客观、公正的职业准则，恪尽职守，为公司提供了高质量的审计服务， 其出具的报告能够客观、真实地反映公司的实际情况、财务状况和经营成果，切实 履行了审计机构职责，从专业角度维护了公司及股东的合法权益。因此，公司拟继 续聘请中审众环会计师事务所（特殊普通合伙）为公司 2025 年度财务报表审计机构， 负责本公司 2025 年报审计工作，聘期一年。 二、拟续聘会计师事务所的 ...

证券代码：002226 证券简称：江南化工 公告编号：2025-074 安徽江南化工股份有限公司 关于召开 2025 年第四次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或 重大遗漏。 一、召开会议的基本情况 1、股东会届次：2025 年第四次临时股东会 2、股东会的召集人：董事会 3、本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易所股票上市规则》《深圳 证券交易所上市公司自律监管指引第 1 号——主板上市公司规范运作》等法律、行政法规、部门规章、 规范性文件及《公司章程》的有关规定。 4、会议时间： （1）现场会议时间：2025 年 12 月 22 日 14:30 （2）网络投票时间：通过深圳证券交易所系统进行网络投票的具体时间为 2025 年 12 月 22 日 9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易所互联网投票系统投票的具体时间为 2025 年 12 月 22 日 9:15 至 15:00 的任意时间。 5、会议的召开方式：现场表决与网络投票相结合。 6、会议的股权登记日：2025 年 1 ...

证券代码：002226 证券简称：江南化工 公告编号:2025-069 安徽江南化工股份有限公司 2、审议通过了《关于公司现金收购西安庆华民用爆破器材股份有限公司 100%股份暨关联交易的议案》。 关联董事杨世泽、代五四、李宏伟、方晓、孙飞回避表决。 关于第七届董事会第十次会议决议的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、董事会会议召开情况 安徽江南化工股份有限公司（以下简称"公司"或"本公司"）第七届董事 会第十次会议于2025年11月27日以电子邮件等方式通知了各位董事，并于2025 年12月5日在本公司会议室采用通讯方式召开。会议应出席董事9名，实际出席董 事9名，公司高级管理人员列席了会议。本次会议由董事长杨世泽先生主持，会 议召开程序符合《公司法》和《公司章程》等有关规定。会议审议通过了如下议 案： 二、董事会会议审议情况 1、审议通过了《关于续聘会计师事务所的议案》。 表决结果：同意 9 票，反对 0 票，弃权 0 票。 详见 2025 年 12 月 6 日登载于《证券时报》《中国证券报》《证券日报》《上 海证券报》和巨潮资讯网的《关于 ...

格隆汇12月5日｜江南化工公告，公司拟以现金方式收购特能集团持有的庆华民爆100%股份，交易金额 为6.45亿元。本次交易构成关联交易，但不构成《上市公司重大资产重组管理办法》规定的上市公司重 大资产重组。本次交易已经公司第七届董事会第十次会议审议通过，尚需提交公司股东会审议批准，关 联股东将回避表决。 ...

Group 1 - Jiangnan Chemical (SZ 002226) announced that its seventh board meeting was held on December 5, 2025, to review the proposal for the fourth extraordinary shareholders' meeting of 2025 [1] - For the first half of 2025, Jiangnan Chemical's revenue composition was as follows: 91.6% from the civil explosives industry, 7.86% from the wind power industry, and 0.53% from other businesses [1] - As of the report date, Jiangnan Chemical's market capitalization was 16.8 billion yuan [1]

Core Viewpoint - The company plans to participate in the public bidding for the transfer project of the emulsified explosive production line and associated assets of Fushun Mining Group's No. 11 Factory, with a starting price of 146 million yuan, and the final amount will be determined by the bidding results [1] Group 1: Transaction Details - The company intends to acquire 18,000 tons of emulsified explosive production capacity through this transfer project [1] - Additionally, the company plans to participate in the overall leasing project of 92 buildings and structures and 41 ancillary equipment from the No. 11 Factory, with a starting price of 52.995 million yuan for a ten-year lease [1] - This transaction does not constitute a related party transaction or a major asset restructuring and falls within the decision-making scope of the company's board of directors, thus not requiring shareholder approval [1] Group 2: Market Context - The transaction will be conducted publicly at the Dalian Property Rights Exchange, indicating potential uncertainties in the bidding process [1]

安徽江南化工股份有限公司 关于以公开摘牌方式受让重庆顺安爆破器材有限公司 100%股权 的进展公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、交易概述 证券代码：002226 证券简称：江南化工 公告编号:2025-068 根据重庆联合产权交易所（以下简称"重庆联交所"）发布的公告信息，重 庆市能源投资集团有限公司（以下简称"重庆能源集团"）持有的重庆顺安爆破 器材有限公司（以下简称"顺安爆破"）100%股权通过公开挂牌方式进行转让， 转让底价为 100,000.00 万元。 2025 年 10 月 10 日，安徽江南化工股份有限公司（以下简称"江南化工" 或"公司"）召开第七届董事会第八次会议，并于 2025 年 10 月 27 日召开 2025 年第三次临时股东会，审议通过了《关于拟公开摘牌重庆顺安爆破器材有限公司 100%股权的议案》。2025 年 11 月 10 日，公司收到重庆联交所发来的《交易结 果通知书（受让方）》。 具体内容详见公司在《中国证券报》《证券时报》《上海证券报》《证券日 报》及巨潮资讯网上披露的《关于拟公开摘牌重庆顺安爆破器材有 ...

Core Viewpoint - Jiangnan Chemical, a leading company in the domestic civil explosives industry, is accelerating its expansion through the acquisition of 100% equity in Chongqing Shun'an Explosives Co., Ltd. for a base price of 1 billion yuan, marking a significant step in its industry consolidation strategy and regional layout enhancement [1][2]. Group 1: Acquisition and Strategic Moves - The acquisition of Shun'an Explosives is a key move for Jiangnan Chemical to deepen its regional layout and respond to industry consolidation policies, reinforcing its leading position in the market [2][3]. - Shun'an Explosives has demonstrated stable profitability, with revenue of 379 million yuan and a net profit of approximately 55.45 million yuan from January to August 2025, alongside a net asset value of 662 million yuan, indicating strong asset quality and stable cash flow [2][3]. Group 2: Financial Performance and Growth - Jiangnan Chemical's total assets have surpassed 20 billion yuan, reaching 20.082 billion yuan, with a year-on-year increase of 6.95%, and equity attributable to shareholders growing by 8.37% [4][6]. - From 2020 to 2024, Jiangnan Chemical's revenue increased from 3.919 billion yuan to 9.481 billion yuan, a growth of 141.9%, while net profit doubled from 447 million yuan to 891 million yuan [4]. - In the first three quarters of 2025, the company reported revenue of 6.885 billion yuan and a net profit of 664 million yuan, reflecting a year-on-year growth of 2.78% in revenue but a decline of 11.4% in net profit [4]. Group 3: Business Operations and Market Position - Jiangnan Chemical focuses on its core civil explosives business, forming a diversified product matrix and full industry chain service capability, with the first half of 2025 seeing revenue from blasting engineering services reach 2.553 billion yuan, a year-on-year increase of 7.32% [5][6]. - The company holds a production capacity of 777,500 tons for industrial explosives, placing it in the leading tier of the industry, and it is recognized for having the most comprehensive range of civil explosive products in China [6].

Core Viewpoint - Jiangnan Chemical's acquisition of 100% equity in Chongqing Shun'an Explosive Materials Co., Ltd. for a base price of 1 billion yuan is a strategic move to expand its presence in the civil explosive industry and align with national industry consolidation policies [1][2]. Group 1: Acquisition Details - The acquisition price for Shun'an Explosive is set at 1 billion yuan, with the assessed value of its equity at 884.44 million yuan, reflecting an increase of 66.59% [1]. - The assessed value of Shun'an Explosive's subsidiary, Chongqing Shun'an Nantong Explosive Materials Co., Ltd., is 112.48 million yuan, with a growth rate of 49.87% [1]. Group 2: Strategic Importance - The acquisition is part of Jiangnan Chemical's broader strategy to tap into market opportunities in regions such as Chongqing, Sichuan, Guizhou, and Yunnan, enhancing its civil explosive sector [1][2]. - The integration is expected to leverage Jiangnan Chemical's expertise in industrial explosives and blasting engineering, improving production efficiency and product quality for Shun'an Explosive [2]. Group 3: Financial Impact - From January to August this year, Shun'an Explosive reported a net profit of 55.45 million yuan, indicating potential for revenue and profit growth for Jiangnan Chemical post-integration [2]. - Jiangnan Chemical has been active in acquisitions, including the integration of 70% equity in Chaoyang Hongshan Chemical Co., Ltd. and a 35.97% stake in Shaanxi Hongqi Civil Explosive Group Co., Ltd. in 2024 [2]. Group 4: Industry Outlook - The civil explosive industry in China is shifting towards high-tech and high-quality development, with a focus on leading companies that possess technological advantages and integrated service capabilities [2]. - The demand for civil explosives is expected to remain stable due to ongoing major infrastructure and mining projects in China [2].

Group 1 - Huayang Intelligent's shareholder, Fosun Weiying, plans to reduce its stake by up to 285.42 million shares, representing no more than 5% of the company [1] - Kangtai Biological's controlling shareholder's concerted actor, Du Xinglian, intends to reduce its stake by up to 272.4 million shares, which is no more than 0.24% of the total share capital [2] - Mindray Medical has submitted an application for H-share issuance and listing on the Hong Kong Stock Exchange [4] Group 2 - Junpu Intelligent's chairman, Liu Yuan, resigned for personal reasons, and Wang Jianfeng was elected as the new chairman [6] - Mingchen Health's actual controller and executives plan to collectively reduce their stake by up to 8.61 million shares, accounting for 3.27% of the total share capital [7] - Zhongheng Design's directors and executives plan to reduce their stake by up to 151.57 million shares, representing no more than 0.55% of the total share capital [9] Group 3 - ST Erya and its actual controller, Zheng Jiping, are still under investigation by the China Securities Regulatory Commission [10] - Qicai Chemical's shareholder, Beijing Fengyan, plans to reduce its stake by up to 399.12 million shares, accounting for 0.98% of the total share capital [11] - Aier Eye Hospital plans to distribute a cash dividend of 0.8 yuan per 10 shares to all shareholders, totaling approximately 744 million yuan [12] Group 4 - Meiri Interactive's actual controller's concerted actor plans to reduce its stake by up to 394.74 million shares, which is 1% of the total share capital [13] - Maipu Medical's pre-IPO shareholder plans to reduce its stake by up to 67.05 million shares, representing no more than 1% of the total share capital [15] - Qinchuan Machine Tool's subsidiary plans to increase its registered capital from 50 million yuan to 200 million yuan, introducing new investors [17] Group 5 - Guiyang Bank's proposed director, Yu Rui, has resigned due to work reasons [19] - Guiyang Bank plans to acquire Xifeng Development Village Bank and establish a branch [20] - Aojing Medical's directors and executives plan to collectively reduce their stake by up to 25.28 million shares, accounting for no more than 0.19% of the total share capital [21] Group 6 - Zhongji Xuchuang intends to issue H-shares and list on the Hong Kong Stock Exchange [22] - ST Huatuo's stock will have its risk warning lifted, changing its name to Shiji Huatuo [25] - *ST Gaohong's stock has been delisted from the Shenzhen Stock Exchange [27] Group 7 - Tianwo Technology plans to publicly transfer a 7.12% stake in Qinghai Haihe Railway Transportation Co., with an assessed value of approximately 8.54 million yuan [28] - Xingye Technology's major shareholder plans to reduce its stake by up to 886.65 million shares, representing no more than 3% of the total share capital [29] - Jiangnan Chemical has successfully acquired 100% equity of Chongqing Shun'an Explosive Materials Co., with a transfer base price of 1 billion yuan [31]